同得仕(集團)(00518.HK)中期由虧轉盈2.4億港元 每股派息共24.37港仙
格隆匯11月27日丨同得仕(集團)(00518.HK)公佈,截至2020年9月30日止6個月,公司收益2.27億港元,同比減少42.6%;公司擁有人應占溢利2.4億港元,上年同期虧損3049萬港元;每股盈利53.2港仙,派付中期股息每股2.2港仙及有關出售一家附屬公司的特別股息每股22.17港仙。
期間毛利率16.4%,較去年同期下降約4.9個百分點。毛利率下降乃主要由於COVID-19疫情對銷售及定價造成的負面影響,以及在銷售基數大幅降低下固定制造開支的量化槓桿效應所致。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.